Intendis, Inc., maker of Finacea (azelaic acid) Gel 15% and Desonate (desonide) Gel 0.05% is changing its name to Bayer Healthcare. Bayer acquired the company five years ago and has decided to change its name as part of a company-wide rebranding effort. "Although Intendis will have a new name and a new look, the company's pioneering tradition in dermatology remains at the heart of everything we do," said Bill Griffing, United States president and general manager for Bayer HealthCare's dermatology unit. "During the past five years, we have focused on bringing the best of both Intendis and Bayer HealthCare to better serve our customers. Clarifying our place in the Bayer family with this name change increases our access to talented experts and resources that will allow us to continue to develop new therapies to improve skin health and the lives of patients with skin conditions."